The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L. Abrams, James A. McCubrey, Franca Stivala et al.|Cell Cycle|2010Cited by 136
Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cellsLinda S. Steelman, James A. McCubrey, Patrick M. Navolanic et al.|Cell Cycle|2011Cited by 91
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistanceJames A. McCubrey, Alberto M. Martelli, Camilla Evangelisti et al.|Leukemia|2008Cited by 80